View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOL/EBSA RIN: 1210-AC07 Publication ID: Fall 2021 
Title: Requirements Related to Prescription Drug Reporting 
Abstract:

This rule would implement the prescription drug reporting requirements that apply to group health plans and health insurance issuers offering coverage in the group and individual markets under section 204 of title II of Division BB of the Consolidated Appropriations Act.

 
Agency: Department of Labor(DOL)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: Undetermined  Unfunded Mandates: Undetermined 
CFR Citation: 29 CFR 2590.716-1    29 CFR 2590.716-2    29 CFR 2590.725-1 to 2590.725-4   
Legal Authority: Pub. L. 116-260, Division BB, Title I and Title II   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Request For Information (RFI)  06/23/2021  86 FR 32813   
RFI Comment Period End  07/23/2021 
Interim Final Rule  11/23/2021  86 FR 66662   
Interim Final Rule Effective  12/23/2021 
Interim Final Rule Applicability Date  12/27/2021 
Interim Final Rule Comment Period End  01/24/2022 
Regulatory Flexibility Analysis Required: Undetermined  Government Levels Affected: Local, State 
Federalism: Yes 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Related Agencies: Joint: TREAS/IRS, HHS/CMS; 
Agency Contact:
Amber Rivers
Director, Office of Health Plan Standards and Compliance Assistance
Department of Labor
Employee Benefits Security Administration
200 Constitution Avenue NW,
Washington, DC 20210
Phone:202 693-8335
Email: rivers.amber@dol.gov